Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples.
about
Molecular diagnosis of leishmaniasis: current status and future applicationsSystematic review of biomarkers to monitor therapeutic response in leishmaniasisFirst case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in SurinameDevelopment of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samplesDiagnosis of parasitic diseases: old and new approachesPhase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda.Diagnostic accuracy of the Leishmania OligoC-TesT and NASBA-Oligochromatography for diagnosis of leishmaniasis in Sudan.Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.Simplified molecular detection of Leishmania parasites in various clinical samples from patients with leishmaniasis.Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis.Molecular approaches for a better understanding of the epidemiology and population genetics of Leishmania.Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites.Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.A real-time PCR assay to estimate Leishmania chagasi load in its natural sand fly vector Lutzomyia longipalpis.Diagnosis of visceral leishmaniasis: developments over the last decade.Post-kala-azar dermal leishmaniasis: recent developments.Diagnosis of parasitic infections: what's going on?Accordance and concordance of PCR and NASBA followed by oligochromatography for the molecular diagnosis of Trypanosoma brucei and Leishmania.Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA.A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis.Leishmania OligoC-TesT as a simple, rapid, and standardized tool for molecular diagnosis of cutaneous leishmaniasis in Peru.Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cellsTreatment assessment by monitoring parasite load in skin biopsies from patients with cutaneous leishmaniasis, using quantitative nucleic acid sequence-based amplification.Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.Evaluation of conjunctival swab as a mass-screening tool for molecular diagnosis of canine visceral leishmaniasis.Rapid and simultaneous detection of three major diarrhea-causing viruses by multiplex real-time nucleic acid sequence-based amplification.Leishmaniasis, Suriname.A nanodiagnostic colorimetric assay for 18S rRNA of Leishmania pathogens using nucleic acid sequence-based amplification and gold nanorods.
P2860
Q24678198-046900C1-3E6C-461F-B7E4-09EB1D26AD5EQ26866450-71AA2EC0-0C64-4B63-B379-67F12FA0AF08Q29353798-07D3ABA2-653B-4218-9B61-B8E704ADCC7FQ29353857-3310EAE3-8037-40C7-A720-245D0FC3296AQ33580745-8BAE8A0D-F6DC-4894-97B3-12E8DA2EC339Q33631307-96DAFFCB-2A10-4081-9188-81053C481B6FQ33651126-9FED1D95-4C79-4F17-B7DC-78F9164443ABQ33697819-DDBF1050-C286-48FD-AB4B-969182D50318Q33748845-8C1365F7-6220-4A2E-84D9-B876E1338F1FQ33827287-456E7918-2318-4ACD-9F0C-F703939DEBF2Q34149839-5677C8BA-6997-497C-84DC-53E612F3C2BAQ36423765-C1681C94-2C3D-43F9-81E8-337BF0B0CE82Q36803937-93DC7D4B-5255-4F86-9DE9-68C7B41BB862Q37183181-4F559B84-0797-48D7-9BA4-E219E5D2891AQ37953841-1057CCD5-404D-44E0-8505-19EF4DC8F01BQ37962676-D2C690E7-A3E4-4400-B4CD-EA55D5DE338DQ38244508-8D5A0E4C-FAB2-4754-ADD2-A7B74559F4DCQ38872485-3947051C-8E41-4365-8466-7FBB57B15B1BQ38967587-9C38A797-C251-40F0-8C34-17A0DA910E10Q38968001-6B9769DC-8EEB-424E-B0A2-94E4AD51EC63Q38995395-CB75F415-0634-4B25-AEED-B5504C3602D9Q39548200-43BCA5BA-0B0B-4AC5-8246-6E107E5B280CQ39549153-9D90B020-1C6D-4A1C-B809-9242AC6B4049Q39552125-3CA9FD48-9B95-4DB8-A298-1C339181A8BAQ41420442-2F6C85DA-DF9D-4599-855D-0B1F457B4247Q41563322-006B0339-2D70-4657-B02B-2894506A9A21Q43230379-361468B3-B76D-49CF-AAC4-0688FC65FFE5Q44986207-61A86B63-BBFE-492A-B95E-76D4F71C106C
P2860
Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@ast
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@en
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@nl
type
label
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@ast
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@en
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@nl
prefLabel
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@ast
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@en
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@nl
P2093
P2860
P1476
Quantitative nucleic acid sequ ...... asites in skin biopsy samples.
@en
P2093
Gerard J Schoone
Henk D F H Schallig
Henry J C de Vries
Jim E Zeegelaar
Leíla I A R C Coelho
Masoom Kassi
Rudy F M Lai A Fat
Wendy F van der Meide
William R Faber
Yusuf Ozbel
P2860
P304
P356
10.1128/JCM.43.11.5560-5566.2005
P407
P577
2005-11-01T00:00:00Z